Timing of Ablation in ECMO-Supported Electrical Storm: A One-Size-Fits-All Approach is Inadequate for Different Substrates - Scorecard - MDSpire

Timing of Ablation in ECMO-Supported Electrical Storm: A One-Size-Fits-All Approach is Inadequate for Different Substrates

  • By

  • Pierre-Grégoire Guinot

  • Charles Guenancia

  • April 28, 2026

  • 0 min

Share

Clinical Scorecard: Timing of Ablation in ECMO-Supported Electrical Storm: A One-Size-Fits-All Approach is Inadequate for Different Substrates

At a Glance

CategoryDetail
Condition
Key MechanismsClarify the differences in arrhythmogenic substrates between AMI and HFrEF.
Target Population
Care Setting

Key Highlights

  • highlight_2

Guideline-Based Recommendations

Diagnosis

    Management

    • A
    • d
    • d
    • a
    • n
    • o
    • t
    • e
    • o
    • n
    • t
    • h
    • e
    • i
    • m
    • p
    • o
    • r
    • t
    • a
    • n
    • c
    • e
    • o
    • f
    • e
    • t
    • i
    • o
    • l
    • o
    • g
    • y
    • -
    • s
    • t
    • r
    • a
    • t
    • i
    • f
    • i
    • e
    • d
    • r
    • e
    • p
    • o
    • r
    • t
    • i
    • n
    • g
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Patients with electrical storm on VA-ECMO, particularly those with HFrEF

        Ablation may benefit those where arrhythmia is the primary hemodynamic driver

        Clinical Best Practices

        • best_practice_2

        References

        Original Source(s)

        Timing of Ablation in ECMO-Supported Electrical Storm: A One-Size-Fits-All Approach is Inadequate for Different Substrates

        • by Pierre-Grégoire Guinot, Charles Guenancia

        • April 28, 2026

        Related Content

        Abnormal active myocardial relaxation by dipyridamole stress test in suspected early-stage heart failure with preserved ejection fraction: a retrospective exploratory analysis

        Senate Report Details Early Myocarditis Signals After COVID-19 Vaccination

        Investigative report cites internal communications, VAERS data, and CDC case reviews describing myocarditis and pericarditis reports in adolescents and young adults after mRNA COVID-19 vaccination.

        Risk stratification for sudden cardiac death in nonischemic dilated cardiomyopathy: a moving target?